Recommandations en Oncologie

79 recommandations en vigueur en Oncologie émanant d’agences nationales, de sociétés savantes européennes et d’organismes d’HTA, réparties sur 13 groupes de sources. eUvidence ancre ses réponses en Oncologie sur ces recommandations ; chaque entrée renvoie à la page de l’organisme émetteur.

Sociétés savantes européennes· 26

• Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2025

• Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2025

• ESMO Clinical Practice Guideline Express Update on the management of metastatic pancreatic cancer

  ESMO · European Society for Medical Oncology · 2025

• Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2025

• Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2025

• Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2024

• Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2024

• ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemia

  ESMO · European Society for Medical Oncology · 2024

• Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2023

• Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2023

• Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2023

• Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2023

• Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2023

• Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2022

• Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2022

• Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2022

• Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2022

• Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2022

• Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2021

• ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

  ESMO · European Society for Medical Oncology · 2021

• Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up

  EHA · European Hematology Association · 2021

• EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

  EANO · European Association of Neuro-Oncology · 2021

• Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2020

• Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2020

• Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2020

• Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines

  ESMO · European Society for Medical Oncology · 2018

Belgique· 3

• Guideline on the management of rectal cancer

  KCE · Belgian Health Care Knowledge Centre · 2016

• Colon cancer: diagnosis, treatment and follow-up

  KCE · Belgian Health Care Knowledge Centre · 2014

• Informed choice on breast cancer screening: messages to support informed decision

  KCE · Belgian Health Care Knowledge Centre · 2014 · recommendation

Danemark· 4

• Oncological Treatment of Inoperable Metastatic Melanoma

  DMCG · Dansk Melanom Gruppe (Danske Multidisciplinaere Cancer Grupper) · 2025

• Curative Radiotherapy for Prostate Cancer

  DMCG · Dansk Prostata Cancer Gruppe (Danske Multidisciplinaere Cancer Grupper) · 2025

• Breast Cancer: Follow-up

  DMCG · Danish Breast Cancer Group (Danske Multidisciplinaere Cancer Grupper) · 2025

• Treatment of Acute Myeloid Leukaemia (AML)

  DMCG · Akut Leukaemi Gruppen (Danske Multidisciplinaere Cancer Grupper) · 2024

France· 9

• Pilot Programme for Organized Lung Cancer Screening — Summary of Retained Proposals

  INCa · Institut National du Cancer · 2024 · recommendation

• Cutaneous Melanomas — From Diagnosis to Follow-up (General Practitioner Practice Tool)

  INCa · Institut National du Cancer · 2024 · good practice guide

• Targeted Biopsies in the Diagnosis of Prostate Cancer

  HAS · Haute Autorité de Santé · 2023 · recommendation

• Patients with Cutaneous or Mucosal Melanoma: Indications for Molecular Testing for Prescribing Precision Treatments

  INCa · Institut National du Cancer · 2023 · recommendation

• National Organizational Reference Framework: Supportive Oncology Care for Adult Cancer Patients

  INCa · Institut National du Cancer · 2021 · good practice guide

• Colorectal Cancer: Screening and Prevention Modalities in Subjects at High and Very High Risk

  HAS · Haute Autorité de Santé · 2017 · recommendation

• Women Carrying a BRCA1 or BRCA2 Mutation: Early Detection of Breast and Adnexal Cancer and Risk-Reduction Strategies (Synthesis)

  INCa · Institut National du Cancer · 2017 · recommendation

• Breast Cancer Screening According to Risk Factor

  HAS · Haute Autorité de Santé · 2014 · recommendation

• Colorectal Cancer Screening and Prevention (Health Examination Centres Reference Document)

  HAS · Haute Autorité de Santé · 2013 · good practice guide

Allemagne· 10

• Colorectal Cancer

  LL-Onko · Leitlinienprogramm Onkologie · 2026

• Supportive Therapy in Oncology Patients

  LL-Onko · Leitlinienprogramm Onkologie · 2026

• Diagnosis, Therapy and Follow-up of Malignant Ovarian Tumors

  LL-Onko · Leitlinienprogramm Onkologie · 2026

• Early Detection, Diagnosis, Therapy and Follow-up of Breast Cancer

  LL-Onko · Leitlinienprogramm Onkologie · 2025

• Prostate Cancer

  LL-Onko · Leitlinienprogramm Onkologie · 2025

• Prevention, Diagnosis, Therapy and Follow-up of Lung Cancer

  LL-Onko · Leitlinienprogramm Onkologie · 2025

• Diagnosis and Therapy of Adenocarcinomas of the Stomach and Esophagogastric Junction

  LL-Onko · Leitlinienprogramm Onkologie · 2025

• Exocrine Pancreatic Cancer

  LL-Onko · Leitlinienprogramm Onkologie · 2024

• Diagnosis, Therapy and Follow-up of Melanoma

  LL-Onko · Leitlinienprogramm Onkologie · 2020

• Palliative Care for Patients with Incurable Cancer

  LL-Onko · Leitlinienprogramm Onkologie · 2020

Irlande· 2

• Diagnosis, Staging and Treatment of Patients with Lung Cancer: National Clinical Guideline No. 16

  NCCP · National Cancer Control Programme, Health Service Executive · 2017

• Diagnosis, Staging and Treatment of Patients with Breast Cancer: National Clinical Guideline No. 7

  NCCP · National Cancer Control Programme, Health Service Executive · 2015

Italie· 1

• Melanoma

  AIOM · Associazione Italiana di Oncologia Medica · 2023

Pays-Bas· 8

• Colorectal Cancer

  FMS · Federatie Medisch Specialisten · 2026

• Melanoma

  FMS · Federatie Medisch Specialisten · 2026

• Breast Cancer

  FMS · Federatie Medisch Specialisten · 2025

• Non-Small Cell Lung Cancer

  FMS · Federatie Medisch Specialisten · 2025

• Gastric Cancer

  FMS · Federatie Medisch Specialisten · 2025

• Esophageal Cancer

  FMS · Federatie Medisch Specialisten · 2024

• Pancreatic Cancer

  FMS · Federatie Medisch Specialisten · 2019

• Prostate Cancer

  FMS · Federatie Medisch Specialisten · 2016

Norvège· 3

• National Action Programme with Guidelines for Colorectal Cancer

  Helsedir · Norwegian Directorate of Health · 2026

• National Action Programme with Guidelines for Breast Cancer

  Helsedir · Norwegian Directorate of Health · 2026

• National Action Programme with Guidelines for Prostate Cancer

  Helsedir · Norwegian Directorate of Health · 2025

Pologne· 2

• Clinical Practice Guideline Recommendation No. 178/2025 on Lung Cancer Screening with Low-Dose Computed Tomography

  AOTMiT · Agencja Oceny Technologii Medycznych i Taryfikacji · 2025 · recommendation

• Diagnostic and Therapeutic Guidelines for Breast Cancer

  PTOK · Polskie Towarzystwo Onkologii Klinicznej · 2020

Portugal· 1

• Breast Carcinoma: Adjuvant Treatment

  DGS · Direcao-Geral da Saude · 2011

Suède· 2

• National Care Programme for Breast Cancer

  RCC · Regional Cancer Centres in Collaboration · 2025

• National Care Programme for Prostate Cancer - Short Version for General Practitioners

  RCC · Regional Cancer Centres in Collaboration · 2025

Royaume-Uni· 8

• Suspected cancer: recognition and referral

  NICE · National Institute for Health and Care Excellence · 2025

• Early and locally advanced breast cancer: diagnosis and management

  NICE · National Institute for Health and Care Excellence · 2025

• Advanced breast cancer: diagnosis and treatment

  NICE · National Institute for Health and Care Excellence · 2025

• Lung cancer: diagnosis and management

  NICE · National Institute for Health and Care Excellence · 2024

• Melanoma: assessment and management

  NICE · National Institute for Health and Care Excellence · 2022

• Colorectal cancer

  NICE · National Institute for Health and Care Excellence · 2021

• Prostate cancer: diagnosis and management

  NICE · National Institute for Health and Care Excellence · 2021

• Pancreatic cancer in adults: diagnosis and management

  NICE · National Institute for Health and Care Excellence · 2018